Ultrasound elastography score to measure pancreatic fat
Official title: Study for the Identification of a Quantitative Eco-Elastographic Score of Pancreatic Steatosis and Its Correlation With Beta-Cell Function and Metabolic Syndrome.
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07155473 · Data updated 2026-11-12
We will test an ultrasound-based score that measures pancreatic fat to see if it links to insulin-producing cell function and diabetes risk in adults with or at risk for metabolic syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Roma, Rome) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | September 4, 2025 |
| Trial ID | NCT07155473 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 who can give informed consent, have HbA1c under 10% (or fasting glucose under 250 mg/dL), and do not have excluded pancreatic or systemic conditions are ideal candidates.
✕Probably not a fit
People with insulin-treated diabetes, very high blood sugars (HbA1c >10% or fasting glucose >250 mg/dL), prior pancreatic surgery, severe liver failure, or active pregnancy/breastfeeding are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study will develop a quantitative ultrasound elastography score to measure pancreatic steatosis and relate that score to metabolic health measures. One hundred participants aged 18–80 will be recruited at Gemelli University Hospital and undergo pancreatic ultrasound elastography, blood tests including C-peptide and glycemic markers, and metabolic profiling. Investigators will create a fat score, compute beta-cell function indices, and classify participants into four metabolic risk classes for type 2 diabetes. Correlations between the pancreatic fat score and measures of beta-cell function and diabetes risk will be analyzed.
Why it matters
Potential benefit: If successful, the score could help identify people at higher risk of type 2 diabetes so clinicians can target monitoring or preventive steps earlier.
How similar studies have gone: Previous imaging work using MRI/CT has linked pancreatic fat to metabolic risk, but quantitative ultrasound elastography for pancreatic fat scoring is relatively new and not yet widely validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Exclusion Criteria * Age \<18 years or \>80 years * History of diabetes treated with insulin * HbA1c \>10% or fasting glucose \>250 mg/dL * Pancreatic diseases (solid tumors/secretory NETs/cystic fibrosis; non-secretory NETs and IPMN may be included) * Previous pancreatic surgery * Moderate anemia (Hb \<10 mg/dL) * Severe liver failure (Child-Pugh C) * Non-metabolic causes of NAPLD (e.g., corticosteroid therapy, antiretrovirals, gemcitabine, octreotide, history of hemochromatosis, malnutrition, HBV/HIV infections) * Alcohol abuse (\>30 g/day of ethanol) * Pregnancy and breastfeeding * Inability to adequately understand informed consent and study procedures Inclusion Criteria: * Age between 18 and 80 years * HbA1c \<10% or fasting glucose \<250 mg/dL * Ability to understand and provide informed consent regarding the procedures, data collection, and analysis.
Where it's running
-
Gemelli University Hospital
Roma, Rome, Italy Recruiting
Study contacts
- Principal investigator: Teresa Mezza — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Teresa Mezza
- Email: teresa.mezza@policlinicogemelli.it
- Phone: +390630155701
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound elastography score for pancreas fat and its link to metabolic health
The team will see if an ultrasound elastography score of pancreatic fat relates to beta-cell function and diabetes risk in adults with metabolic syndrome or diabetes.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.